Hillhurst Biopharmaceuticals, Inc.
Clinical trials sponsored by Hillhurst Biopharmaceuticals, Inc., explained in plain language.
-
Could carbon monoxide help Parkinson's? small trial begins
Symptom relief Recruiting nowThis phase 2a trial tests an oral liquid containing low-dose carbon monoxide (HBI-002) in 36 people with Parkinson's disease. Participants take it daily for 14 days to see if it is safe and tolerable. The study is randomized and placebo-controlled, meaning some get the drug and s…
Phase: PHASE2 • Sponsor: Hillhurst Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Could carbon monoxide be a medicine? new trial for sickle cell
Symptom relief Recruiting nowThis study tests a new liquid drug called HBI-002, which contains carbon monoxide, in 9 people with sickle cell disease aged 14 to 55. Participants take the drug daily for 14 days to see if it is safe and helps with symptoms. The goal is to find a better way to manage this painfu…
Phase: PHASE1, PHASE2 • Sponsor: Hillhurst Biopharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC